Grail Stock Soars 20%, Leading Nasdaq 100 Gains
Grail stock surged 20%, leading the Nasdaq 100, after projecting strong revenue growth for its Galleri cancer test and ample cash reserves into 2028. This jump suggests renewed investor confidence in Grail’s early cancer detection technology.